• Noble and Aptar Pharma Launch AdhereIT™ Connected Onboarding Solution

    News: 

    Noble and Aptar Pharma are pleased to announce the launch of AdhereIT™ – a connected, intuitive and user-friendly onboarding solution for the growing number of patients with chronic conditions who use autoinjectors to administer their medications at home. AdhereIT™ is the first fully interchangeable, connected add-on solution that can work across a multitude of autoinjector platforms. This launch is an important advancement for Noble, an Aptar Pharma company, whose mission is to foster healthy outcomes for patients who self-administer their therapies, partnering with pharma and biotech companies to provide robust training devices and onboarding programs.

    Adherence to prescribed biologics is a significant challenge. A recent report in the Journal of the American Academy of Dermatology reported that 45% of studied patients suffering from psoriasis discontinue their treatments. The reasons include insufficient training or time with an instructor, lack of confidence during the self-injection process, and feelings of high anxiety and lack of control. COVID-19 has contributed to the increase utilization of telemedicine and remote healthcare, which has even further complicated this challenge by reducing healthcare professional (HCP) training opportunities with patients.

    AdhereIT™ is part of the digital ecosystem that enables patients to gain control and confidence over their at-home drug delivery while easing the anxiety associated with self-injecting. AdhereIT™ integrates with the existing software applications developed by the Digital Healthcare team at Aptar Pharma by pairing a patient’s autoinjector via Bluetooth technology to their mobile phone. The device – available in two design options to accommodate dexterity for a one-handed or two-handed injection process – precisely detects an injection event and provides real-time visual, audio and haptic feedback about whether the injection was performed correctly. The AdhereIT™ onboarding platform also allows HCPs to monitor their patients’ therapeutic performance via a smart analytical dashboard, providing valuable patient-specific adherence behavior information.

    “We are excited to welcome Noble’s AdhereIT™ connected onboarding platform into the suite of Aptar Pharma’s Digital Healthcare solutions. This innovative technology further enhances our ability to improve patients’ lives by creating a seamless integration of injectable products into our disease management offerings,” said Adam Shain, Director of Business Development for Digital Healthcare, Aptar Pharma.

    Noble developed AdhereIT™ in partnership with Aptar Pharma, who has made significant investments in digital healthcare over the past three years to actively develop a portfolio of disease management platforms and connected device solutions across dermal, pulmonary, nasal, ophthalmic and injectable routes of administration.

    “Connected medical devices represent the future of healthcare for patients, pharmaceutical companies, health insurers and HCPs, playing a vital role in the remote tracking and treatment of chronic illnesses, and delivering a range of benefits that include improved drug management, enriched patient experiences and enhanced patient outcomes,” said Tim McLeroy, Noble’s Executive Director of Marketing & Patient Services. “The connectivity of digital technology solutions like AdhereIT™ also create market differentiation and enable value-based contracting for biopharmaceutical companies and medical device manufacturers to survive in a competitive and challenging marketplace.”

  • Nemera breaks ground in Brazil through Milfra acquisition

    With this acquisition Nemera establishes an operational footprint in Brazil and expands its product and services offering to better serve the pharmaceutical industry in Latin America.

  • ADMV becomes a sub-brand of FlexLink

    News: 

    From the beginning of 2021 ADMV will again be run as a separate sub-brand within FlexLink. This serves the sustainable diversification in the product range and a clear positioning of the solution offer. It is also intended to strengthen customer relationships and simplify communication in the market. In the future, ADMV will act as an expert brand with a focus on beginning-of-line and in-line applications.
    Extensive industry knowledge and high modularity
    The ADMV team, based in Crémieu near Lyon in France, designs and manufactures feeding machines such as bulk material feeders and step conveyors, handling and assembly machines as well as collaborative robot applications. The machines ensure gentle product handling, avoid efficiency losses due to congestion and enable seamless speed changes. A high degree of modularity and flexibility enables line modifications for quick adaptation to production changes and thus shortens the time to market.
     

  • 2021 FINAT Awards: Schreiner Group Scores Big

    At this year’s FINAT Awards presentation, Schreiner Group celebrated an outstanding success: The high-tech company impressed the judging panel in as many as four different categories. A particularly remarkable prize, the prestigious Innovation Award, went to PlasmaPatch from Schreiner ProTech using printed electronics for wound healing.

  • ASPA and Messe Frankfurt India to unite experts to discuss ideas for securing the pharmaceutical supply chain

    Increasing instances of substandard, falsified and counterfeit medical products continue to pose a major challenge to the global healthcare system which is already suffering from the dire impact of COVID-19. To address this issue, ASPA and Messe Frankfurt India will unite leading experts from the pharmaceutical segment for a live panel discussion on 11 June 2021.

  • GUALAPACK, ITALIAN COMPANY AND GLOBAL LEADER IN FLEXIBLE PACKAGING, ANNOUNCES IT HAS ACQUIRED A MAJORITY STAKE IN EASYSNAP TECHNOLOGY

     Guala Pack S.p.A. has announced its acquisition of the majority stake in Easysnap Technology, a company from the Italian Packaging Valley, globally renowned for its patented Easysnap® technology, an innovative system to easily open single-dose packets.

  • Airnov innovations help maximize oxygen protection in pharmaceutical and nutraceutical products

    Oxynov™ Barrier Bottles and Pharmakeep® – an oxygen and moisture absorber designed to protect oxygen sensitive products
    Stablus™ shelf-life predictive simulator provides key insight into oxygen protection to inform which protective solutions should be used
    Solutions combine to improve oxygen protection and reduce product development time and costs

  • Packaging and Labeling Innovation E-Conference 2021

    Packaging and Labeling Innovation E-Conference 2021  is the perfect platform for solution providers and other industry professionals to share and exchange their experiences on all aspects of Smart Packaging and other issues that are rarely addressed. This PLIP 2021 Conference will dive deep inside the workings of New strategies, practical challenges, most recent innovations, and solutions adopted in the fields of Sustainable, Green packaging, and the Internet of things of the Packaging Industry. At this E-Conference all the stakeholders will get an opportunity to interact with Packaging Heads, Buyers, Category Heads, Procurement  Directors, Purchasing & Outsourcing Managers, Labeling Head, Directors, and Managers globally.

    To resgister  follow link : https://pgsolx.com/supplychain/PLIP-ASIA-P/

  • Marchesini Group takes part in Achema Pulse, the digital event that provides a foretaste of 2022’s international show

    Pianoro (Bologna) – In the run-up to the next edition of Achema (4-8 April 2022), the industry’s first big international event after the stop imposed by the pandemic, the German show’s organisers have launched the Achema Pulse digital portal. The platform will be online throughout the month of June, with two red-letter dates, the Live Days on 15 and 16 June, when industry players will present the new process and packaging trends.

  • Zydus’ new tech enabled initiative to safeguard patients against counterfeit drugs

    News: 

    Zydus Cadila, an innovation-driven pharmaceutical company announced that it has introduced a new feature in the packaging of its critical drugs to help patients ensure that the product is not fake or counterfeited. The company has incorporated a new IT enabled scratch code which shall be printed under a scratchable surface. The patients can check to see if the product purchased by them is genuine or not by scratching the surface and verifying the code through the app or the website. This security feature developed by Hyperlink Infosystem enables patients and institutions detect counterfeits. All that one needs to do is scratch the code and immediately verify this on an app or website, in no time.

    With increasing instances of counterfeit products in the market it was necessary to ensure that a 100% genuine product of Zydus is available to patients. To start with the technology is being implemented in the Company’s products Remdac (Remdesivir) and Virafin Inj (Pegylated Interpheron Alpha 2b) and will be seen on the product packs in the third week of June. The new feature will also be extended to other products of the company.

    Speaking on the new initiative Dr. Sharvil Patel, Managing Director, Cadila Healthcare Ltd., said, “The problem of counterfeit drugs undermines the painstaking efforts that are put in to ensure that the end user or patients receive a product that is safe and manufactured with the highest standards of quality excellence. Counterfeit drugs can be harmful as they may not have the desired outcome and could also be life threatening in some cases. To curb this menace we looked at a user friendly solution which can reassure the patient that the product is genuine and safe. Zydus Verify is a techenabled solution that will safeguard patients against counterfeit drugs.”

    How does ‘Zydus Verify’ work?

     Each pack has a concealed secret code which comes with a scratchable surface

     The customer who buys the pack, scratches the surface and finds a code

     He/She downloads Zydus Verify App from Google Play store and Apple Store or visits the website and enters the code on the pack

     The App connects the code and flashes the brand name verifying a genuine purchase.

  • Pages